In vivo selection of anti-glioblastoma DNA aptamers in an orthotopic patient-derived xenograft model is a research paper published in NAR Cancer (2025). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Mayo Clinic
Grant: UL1TR000135
NIH
Grant: R35GM143949
NIH
Grant: R61NS128071-01A1
NINDS NIH HHS
Grant: R61 NS128071
NIH
Grant: T32GM145408
National Institutes of Health
Grant: 5T32GM145408-02
MSTP at Mayo Clinic Rochester
National Institutes of Health
Grant: 5R35GM143949-03
Fundamental and applied studies of nucleic acids
National Institutes of Health
Grant: 1R61NS128071-01A1
In vivo SELEX strategies to identify potent aptamer-drug conjugates for glioblastoma
National Institutes of Health
Grant: 5UL1TR000135-08
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
Fields of Study
MeSH Terms
Keywords